Login / Signup

Comparison of the Real-World Reporting of Symptoms and Well-Being for the HER2-Directed Trastuzumab Biosimilar Ogivri With Registry Data for Herceptin in the Treatment of Breast Cancer: Prospective Observational Study (OGIPRO) of Electronic Patient-Reported Outcomes.

Andreas TrojanSven RothZiad AtassiMichael KiesslingReinhard ZenhaeusernYannick KadvanyJohannes SchumacherGerd A Kullak-UblickMatti AaproAlexandru E Eniu
Published in: JMIR cancer (2024)
ClinicalTrials.gov NCT05234021; https://clinicaltrials.gov/study/NCT05234021.
Keyphrases
  • patient reported outcomes
  • emergency department
  • big data
  • adverse drug
  • combination therapy
  • sleep quality
  • metastatic breast cancer
  • clinical evaluation